(CG1) Amundi DAX DR - Ratings and Ratios
Dax, Stocks, Germany, LargeCaps
Description: CG1 Amundi DAX DR
The Amundi ETF DAX UCITS ETF DR is an exchange-traded fund (ETF) that tracks the DAX index, providing investors with exposure to the German equity market. As a Germany Equity ETF, it is designed to replicate the performance of the DAX, which comprises the 40 largest and most liquid German stocks.
The funds assets under management (AUM) stand at approximately €1.615 billion, indicating a moderate level of investor interest. The ETFs liquidity profile, as measured by average trading volume, is relatively modest at around 1,796 shares per day.
Key economic drivers for the DAX index, and by extension this ETF, include Germanys economic growth, industrial production, and export activity. The index is heavily weighted towards industrials, automotives, and technology, making it sensitive to global trade trends and economic cycles. Key performance indicators (KPIs) to monitor include GDP growth, manufacturing PMI, and the eurozones monetary policy decisions.
From a technical analysis perspective, the ETFs price action is closely tied to the underlying DAX index. The current price is near its 20-day simple moving average (SMA), indicating a stable short-term trend. The longer-term 200-day SMA suggests a bullish trend, with the ETFs price significantly above this level. Volatility, as measured by average true range (ATR), is relatively low, indicating stable market conditions.
To evaluate the ETFs potential performance, investors should focus on the underlying DAX indexs constituent stocks, their earnings growth, and the overall German economic landscape. A thorough analysis of these factors can provide insights into the ETFs potential future returns and help investors make informed decisions.
CG1 ETF Overview
Market Cap in USD | 1,733m |
Category | Germany Equity |
TER | 0.10% |
IPO / Inception | 2008-09-16 |
CG1 ETF Ratings
Growth Rating | 87.8% |
Fundamental | - |
Dividend Rating | - |
Return 12m vs S&P 500 | 4.99% |
Analyst Rating | - |
CG1 Dividends
Currently no dividends paidCG1 Growth Ratios
Growth Correlation 3m | -1.3% |
Growth Correlation 12m | 88.6% |
Growth Correlation 5y | 80.5% |
CAGR 5y | 18.56% |
CAGR/Max DD 3y (Calmar Ratio) | 1.17 |
CAGR/Mean DD 3y (Pain Ratio) | 8.39 |
Sharpe Ratio 12m | 0.92 |
Alpha | 6.63 |
Beta | 0.960 |
Volatility | 13.35% |
Current Volume | 1.4k |
Average Volume 20d | 1.2k |
Stop Loss | 410.6 (-3%) |
Signal | -0.69 |
What is the price of CG1 shares?
Over the past week, the price has changed by -1.73%, over one month by +2.15%, over three months by -2.18% and over the past year by +21.23%.
Is Amundi DAX DR a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CG1 is around 436.00 EUR . This means that CG1 is currently overvalued and has a potential downside of 2.99%.
Is CG1 a buy, sell or hold?
What are the forecasts/targets for the CG1 price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 490.7 | 15.9% |
CG1 Fundamental Data Overview
Market Cap EUR = 1.49b (1.49b EUR * 1.0 EUR.EUR)
Beta = 0.96
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.49b EUR (1.49b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 1.49b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.49b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 25.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.55% (E(1.49b)/V(1.49b) * Re(9.55%) + (debt-free company))
Discount Rate = 9.55% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)